A Research Study to Compare Two Types of Insulin, a New Weekly Insulin, Insulin Icodec and an Available Daily Insulin, Insulin Glargine, Both in Combination With Mealtime Insulin, in People With Type 2 Diabetes Who Use Daily Insulin and Mealtime Insulin (ONWARDS 4)
Condition: Diabetes Mellitus, Type 2 Interventions: Drug: Insulin icodec; Drug: Insulin glargine; Drug: Insulin aspart Sponsor: Novo Nordisk A/S Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 11, 2021 Category: Research Source Type: clinical trials
A Research Study to Compare Two Types of Insulin, a New Weekly Insulin, Insulin Icodec and an Available Daily Insulin, Insulin Glargine, Both in Combination With Mealtime Insulin, in People With Type 2 Diabetes Who Use Daily Insulin and Mealtime Insulin (ONWARDS 4)
Condition: Diabetes Mellitus, Type 2 Interventions: Drug: Insulin icodec; Drug: Insulin glargine; Drug: Insulin aspart Sponsor: Novo Nordisk A/S Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 11, 2021 Category: Research Source Type: clinical trials
Insulin Glargine U300 vs Insulin Degludec U100 in Impact on the Glycaemic and Cardiovascular Factors
Condition: Diabetes Mellitus, Type 2 Interventions: Drug: Degludec; Drug: Glargine U300 Sponsors: University of Split, School of Medicine; Pavle Vrebalov Cindro; Jonatan Vuković; Darko Modun; Božo Smajić; Gordan Kardum; Tina Tičinović Kurir; Doris Rušić; Ana Šešelja Perišin; Josipa Bukić Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 31, 2020 Category: Research Source Type: clinical trials
